CD44 isoforms are often upregulated in gastric cancer and have been associated with increased metastatic potential and poor survival. To evaluate the functional impact of O-glycan truncation on CD44 we have analysed glyco-engineered cancer cell models displaying shortened O-glycans. Here, we demonstrate that induction of aberrant O-glycan termination through various molecular mechanisms affects CD44 molecular features. We show that CD44 is a major carrier of truncated O-glycans and that this truncation is accompanied by an increased hyaluronan binding capacity and affects extracellular shedding. In addition, short O-glycans promoted the colocalization of CD44v6 with the receptor tyrosine kinase RON and concomitantly increased activation. Our in vitro findings were validated in gastric cancer clinical samples.

Mereiter, S., Martins, A.M., Gomes, C., Balmana, M., Macedo, J.A., Polom, K., et al. (2019). O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer. FEBS LETTERS, 593(13), 1675-1689 [10.1002/1873-3468.13432].

O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer

Polom K.;Roviello F.;
2019

Abstract

CD44 isoforms are often upregulated in gastric cancer and have been associated with increased metastatic potential and poor survival. To evaluate the functional impact of O-glycan truncation on CD44 we have analysed glyco-engineered cancer cell models displaying shortened O-glycans. Here, we demonstrate that induction of aberrant O-glycan termination through various molecular mechanisms affects CD44 molecular features. We show that CD44 is a major carrier of truncated O-glycans and that this truncation is accompanied by an increased hyaluronan binding capacity and affects extracellular shedding. In addition, short O-glycans promoted the colocalization of CD44v6 with the receptor tyrosine kinase RON and concomitantly increased activation. Our in vitro findings were validated in gastric cancer clinical samples.
Mereiter, S., Martins, A.M., Gomes, C., Balmana, M., Macedo, J.A., Polom, K., et al. (2019). O-glycan truncation enhances cancer-related functions of CD44 in gastric cancer. FEBS LETTERS, 593(13), 1675-1689 [10.1002/1873-3468.13432].
File in questo prodotto:
File Dimensione Formato  
O‐glycan truncation-Mereiter-2019.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 5.82 MB
Formato Adobe PDF
5.82 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/1136576